RxDoctor Payments Data

Cecil Beehler, MD

Family Medicine · Clayton, GANPI 1558332916

Payments from drug & device makers

$496in general payments, 2019–2025

Across 27 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$132
  • Novo Nordisk$64
  • Lilly USA, LLC$54
  • Amarin Pharma, Inc.$48
  • Exact Sciences$42
  • GSK$37
  • plus $119 from 5 others

What the payments were for

  • Food & beverage$496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$496 in reported general payments places this provider in the 45th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$230,132
Medicare patients
477
Services billed
4,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide127$150,680
MounjaroTirzepatide73$112,911
JardianceEmpagliflozin57$90,303
FarxigaDapagliflozin Propanediol69$79,513
EliquisApixaban61$55,562
TrulicityDulaglutide33$30,803
RybelsusSemaglutide15$26,531
JanumetSitagliptin Phos/Metformin Hcl15$16,684
Repatha SureclickEvolocumab16$14,580
SynthroidLevothyroxine Sodium104$7,906
Rosuvastatin Calcium476$5,490
VascepaIcosapent Ethyl16$5,431
Fentanyl23$5,284
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$3,980
Lisdexamfetamine Dimesylate17$3,744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$64$177,211142 claims
Lilly USA, LLCMounjaro, Trulicity$54$143,715106 claims
Boehringer IngelheimJardiance$34$90,30357 claims
AstraZenecaFarxiga$15$79,51369 claims
PfizerEliquis$35$55,56261 claims
AbbVieSynthroid$132$7,906104 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Clayton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →